250 related articles for article (PubMed ID: 30374000)
1. [Bone and calcium metabolism associated with malignancy. Tumor-induced osteomalacia.].
Fukumoto S
Clin Calcium; 2018; 28(11):1451-1455. PubMed ID: 30374000
[TBL] [Abstract][Full Text] [Related]
2. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
3. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
4. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Induced Osteomalacia.
Florenzano P; Hartley IR; Jimenez M; Roszko K; Gafni RI; Collins MT
Calcif Tissue Int; 2021 Jan; 108(1):128-142. PubMed ID: 32504138
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer.
Abramson M; Glezerman IG; Srinivasan M; Ross R; Flombaum C; Gutgarts V
Clin Nephrol; 2021 Feb; 95(2):104-111. PubMed ID: 33191899
[TBL] [Abstract][Full Text] [Related]
8. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
9. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
[TBL] [Abstract][Full Text] [Related]
11. Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report.
Oe Y; Kameda H; Nomoto H; Sakamoto K; Soyama T; Cho KY; Nakamura A; Iwasaki K; Abo D; Kudo K; Miyoshi H; Atsumi T
Medicine (Baltimore); 2021 Nov; 100(46):e27895. PubMed ID: 34797338
[TBL] [Abstract][Full Text] [Related]
12. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
13. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].
Kinoshita Y
Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120
[TBL] [Abstract][Full Text] [Related]
14. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.
Li X; Jiang Y; Huo L; Wu H; Liu Y; Jin J; Yu W; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Chi Y; Jiajue R; Cui L; Meng X; Xia W
J Bone Miner Res; 2020 Mar; 35(3):469-477. PubMed ID: 31643101
[TBL] [Abstract][Full Text] [Related]
15. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
17. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
Kim I; Rajani R
J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced osteomalacia.
Florenzano P; Gafni RI; Collins MT
Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
[TBL] [Abstract][Full Text] [Related]
20. Burosumab in tumor-induced osteomalacia: A case report.
Day AL; Gutiérrez OM; Guthrie BL; Saag KG
Joint Bone Spine; 2020 Jan; 87(1):81-83. PubMed ID: 31382017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]